Astrapterocarpan isolated from Astragalus membranaceus inhibits proliferation of vascular smooth muscle cells

Susumu Ohkawara, Yasunobu Okuma, Takashi Uehara, Takashi Yamagishi, Yasuyuki Nomura

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The inhibitory effects of astrapterocarpan, formononetin, and calycosin isolated from Astragalus membraneceus on platelet-derived growth factor (PDGF)-BB-induced proliferative response in rat vascular smooth muscle cells (A10 cells) were investigated. Astrapterocarpan significantly inhibited PDGF-BB-induced cell proliferation and DNA synthesis in a concentration- dependent manner. This inhibition was not attributed to toxicity. In contrast, formononetin and calycosin had no effect. We next examined the effect of astrapterocarpan on PDGF-BB signal transduction. Astrapterocarpan inhibited PDGF-BB-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERIC1/2) mitogen-activated protein (MAP) kinase. However, this compound had no effect on phosphorylation of PDGF-β-receptor, Akt kinase and p38 MAP kinase. These results indicated that astrapterocarpan inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and that this effect may be mediated, at least in part, by inhibition of the ERK1/2 MAP kinase cascade.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalEuropean Journal of Pharmacology
Volume525
Issue number1-3
DOIs
Publication statusPublished - Nov 21 2005
Externally publishedYes

Fingerprint

Astragalus membranaceus
Vascular Smooth Muscle
Smooth Muscle Myocytes
Mitogen-Activated Protein Kinase 1
Phosphorylation
Cell Proliferation
Platelet-Derived Growth Factor Receptors
Mitogen-Activated Protein Kinase 3
antineoplaston A10
p38 Mitogen-Activated Protein Kinases
Signal Transduction
Phosphotransferases
platelet-derived growth factor BB
DNA

Keywords

  • Astragalus membraneceus
  • Astrapterocarpan
  • Cardiovascular disease
  • Platelet-derived growth factor
  • Vascular smooth muscle cell

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Astrapterocarpan isolated from Astragalus membranaceus inhibits proliferation of vascular smooth muscle cells. / Ohkawara, Susumu; Okuma, Yasunobu; Uehara, Takashi; Yamagishi, Takashi; Nomura, Yasuyuki.

In: European Journal of Pharmacology, Vol. 525, No. 1-3, 21.11.2005, p. 41-47.

Research output: Contribution to journalArticle

Ohkawara, Susumu ; Okuma, Yasunobu ; Uehara, Takashi ; Yamagishi, Takashi ; Nomura, Yasuyuki. / Astrapterocarpan isolated from Astragalus membranaceus inhibits proliferation of vascular smooth muscle cells. In: European Journal of Pharmacology. 2005 ; Vol. 525, No. 1-3. pp. 41-47.
@article{58ffecc807b246e3816a665cdb04c407,
title = "Astrapterocarpan isolated from Astragalus membranaceus inhibits proliferation of vascular smooth muscle cells",
abstract = "The inhibitory effects of astrapterocarpan, formononetin, and calycosin isolated from Astragalus membraneceus on platelet-derived growth factor (PDGF)-BB-induced proliferative response in rat vascular smooth muscle cells (A10 cells) were investigated. Astrapterocarpan significantly inhibited PDGF-BB-induced cell proliferation and DNA synthesis in a concentration- dependent manner. This inhibition was not attributed to toxicity. In contrast, formononetin and calycosin had no effect. We next examined the effect of astrapterocarpan on PDGF-BB signal transduction. Astrapterocarpan inhibited PDGF-BB-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERIC1/2) mitogen-activated protein (MAP) kinase. However, this compound had no effect on phosphorylation of PDGF-β-receptor, Akt kinase and p38 MAP kinase. These results indicated that astrapterocarpan inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and that this effect may be mediated, at least in part, by inhibition of the ERK1/2 MAP kinase cascade.",
keywords = "Astragalus membraneceus, Astrapterocarpan, Cardiovascular disease, Platelet-derived growth factor, Vascular smooth muscle cell",
author = "Susumu Ohkawara and Yasunobu Okuma and Takashi Uehara and Takashi Yamagishi and Yasuyuki Nomura",
year = "2005",
month = "11",
day = "21",
doi = "10.1016/j.ejphar.2005.08.063",
language = "English",
volume = "525",
pages = "41--47",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Astrapterocarpan isolated from Astragalus membranaceus inhibits proliferation of vascular smooth muscle cells

AU - Ohkawara, Susumu

AU - Okuma, Yasunobu

AU - Uehara, Takashi

AU - Yamagishi, Takashi

AU - Nomura, Yasuyuki

PY - 2005/11/21

Y1 - 2005/11/21

N2 - The inhibitory effects of astrapterocarpan, formononetin, and calycosin isolated from Astragalus membraneceus on platelet-derived growth factor (PDGF)-BB-induced proliferative response in rat vascular smooth muscle cells (A10 cells) were investigated. Astrapterocarpan significantly inhibited PDGF-BB-induced cell proliferation and DNA synthesis in a concentration- dependent manner. This inhibition was not attributed to toxicity. In contrast, formononetin and calycosin had no effect. We next examined the effect of astrapterocarpan on PDGF-BB signal transduction. Astrapterocarpan inhibited PDGF-BB-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERIC1/2) mitogen-activated protein (MAP) kinase. However, this compound had no effect on phosphorylation of PDGF-β-receptor, Akt kinase and p38 MAP kinase. These results indicated that astrapterocarpan inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and that this effect may be mediated, at least in part, by inhibition of the ERK1/2 MAP kinase cascade.

AB - The inhibitory effects of astrapterocarpan, formononetin, and calycosin isolated from Astragalus membraneceus on platelet-derived growth factor (PDGF)-BB-induced proliferative response in rat vascular smooth muscle cells (A10 cells) were investigated. Astrapterocarpan significantly inhibited PDGF-BB-induced cell proliferation and DNA synthesis in a concentration- dependent manner. This inhibition was not attributed to toxicity. In contrast, formononetin and calycosin had no effect. We next examined the effect of astrapterocarpan on PDGF-BB signal transduction. Astrapterocarpan inhibited PDGF-BB-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERIC1/2) mitogen-activated protein (MAP) kinase. However, this compound had no effect on phosphorylation of PDGF-β-receptor, Akt kinase and p38 MAP kinase. These results indicated that astrapterocarpan inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and that this effect may be mediated, at least in part, by inhibition of the ERK1/2 MAP kinase cascade.

KW - Astragalus membraneceus

KW - Astrapterocarpan

KW - Cardiovascular disease

KW - Platelet-derived growth factor

KW - Vascular smooth muscle cell

UR - http://www.scopus.com/inward/record.url?scp=28044431625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28044431625&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2005.08.063

DO - 10.1016/j.ejphar.2005.08.063

M3 - Article

VL - 525

SP - 41

EP - 47

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -